Investors are eyeing potential rebounds in three notable stocks: Pfizer (PFE), General Mills (GIS), and United Parcel Service (UPS), all of which have seen significant declines from their recent highs. Pfizer, down about 50% from its peak, faces challenges like patent expirations and competition in the GLP-1 weight-loss market, but its $150 billion market cap and ongoing drug development efforts suggest a recovery is possible.
General Mills has dropped 60% from its 2023 high due to inflationary pressures and changing consumer preferences, yet its strong brand portfolio and commitment to reworking its strategy indicate potential for future growth. Meanwhile, UPS, which has seen a 50% decline, is undergoing a business overhaul aimed at enhancing profitability by focusing on higher-margin customers.
For investors, these stocks not only present opportunities for long-term gains but also offer attractive dividend yields—6.5% for Pfizer, 7% for General Mills, and 6.6% for UPS—providing income while waiting for recovery.
Source: fool.com